Causes, consequences, and perspectives in the variations of intestinal density of colonization of multidrug-resistant enterobacteria

Frontiers in Microbiology

Volumn 4, Issue MAY, 2013, Pages

  Ruppé, Etienne ^a   Andremont, Antoine ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Antibiotics; Carriage; Concentration; Extended spectrum beta lactamases; Microbiota

Indexed keywords

AMOXICILLIN; BETA LACTAM; BETA LACTAMASE; BISMUTH; CARBAPENEMASE; CEPHALOSPORIN; GENTAMICIN; METRONIDAZOLE; PROBIOTIC AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; DENSITY; DRUG EXPOSURE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; HUMAN; HYGIENE; INTESTINE FLORA; MICROBIAL DIVERSITY; NONHUMAN; PSEUDOMONAS AERUGINOSA; TRANSPLANTATION; URINARY TRACT INFECTION;

ENTEROBACTERIACEAE;

EID: 84884249133     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2013.00129     Document Type: Article

References (89)

1. Antonopoulos, D. A., Huse, S. M., Morrison, H. G., Schmidt, T. M., Sogin, M. L., and Young, V. B. (2009). Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect. Immun. 77, 2367-2375.
2. Bakken, J. S. (2009). Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 15, 285-289.
3. Baquero, F., Tedim, A. P., and Coque, T. M. (2013). Antibiotic resistance shaping multi-level population biology of bacteria. Front. Microbiol. 4:15. doi: 10.3389/fmicb.2013.00015
4. Ben-Ami, R., Rodriguez-Bano, J., Arslan, H., Pitout, J. D., Quentin, C., Calbo, E. S., et al. (2009). A multinational survey of risk factors for infection with extendedspectrum beta-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clin. Infect. Dis. 49, 682-690.
5. Berg, R. D. (1981). Promotion of the translocation of enteric bacteria from the gastrointestinal tracts of mice by oral treatment with penicillin, clindamycin, or metronidazole. Infect. Immun. 33, 854-861.
6. Berg, R. D., and Garlington, A. W. (1979). Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect. Immun. 23, 403-411.
7. Bhalla, A., Pultz, N. J., Ray, A. J., Hoyen, C. K., Eckstein, E. C., and Donskey, C. J. (2003). Antianaerobic antibiotic therapy promotes overgrowth of antibioticresistant, gram-negative bacilli and vancomycin-resistant enterococci in the stool of colonized patients. Infect. Control Hosp. Epidemiol. 24, 644-649.
8. Brautigam, H. H., Knothe, H., and Rangoonwala, R. (1988). Impact of cefotaxime and ceftriaxone on the bowel and vaginal flora after single-dose prophylaxis in vaginal hysterectomy. Drugs 35(Suppl. 2), 163-168.
9. Brun-Buisson, C., Legrand, P., Rauss, A., Richard, C., Montravers, F., Besbes, M., et al. (1989). Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. Ann. Intern. Med. 110, 873-881.
10. Buck, A. C., and Cooke, E. M. (1969). The fate of ingested Pseudomonas aeruginosa in normal persons. J. Med. Microbiol. 2, 521-525.
11. Clatworthy, A. E., Pierson, E., and Hung, D. T. (2007). Targeting virulence: a new paradigm for antimicrobial therapy. Nat. Chem. Biol. 3, 541-548.
12. Cooke, E. M., Hettiaratchy, I. G., and Buck, A. C. (1972). Fate of ingested Escherichia coli in normal persons. J. Med. Microbiol. 5, 361-369.
13. Cosgrove, S. E., Patel, A., Song, X., Miller, R. E., Speck, K., Banowetz, A., et al. (2007). Impact of different methods of feedback to clinicians after postprescription antimicrobial review based on the centers for disease control and prevention's 12 steps to prevent antimicrobial resistance among hospitalized adults. Infect. Control Hosp. Epidemiol. 28, 641-646.
14. Cuzon, G., Naas, T., Bogaerts, P., Glupczynski, Y., and Nordmann, P. (2012). Evaluation of a DNA microarray for the rapid detection of extended-spectrum β- lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM). J. Antimicrob. Chemother. 67, 1865-1869.
15. Datta, R., Platt, R., Yokoe, D. S., and Huang, S. S. (2011). Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants. Arch. Intern. Med. 171, 491-494.
16. Davey, P., Brown, E., Fenelon, L., Finch, R., Gould, I., Hartman, G., et al. (2005). Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst. Rev. CD003543.
17. de Lastours, V., Cambau, E., Guillard, T., Marcade, G., Chau, F., and Fantin, B. (2012). Diversity of individual dynamic patterns of emergence of resistance to quinolones in Escherichia coli from the fecal flora of healthy volunteers exposed to ciprofloxacin. J. Infect. Dis. 206, 1399-1406.
18. de Smet, A. M., Kluytmans, J. A., Blok, H. E., Mascini, E. M., Benus, R. F., Bernards, A. T., et al. (2011). Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study. Lancet Infect. Dis. 11, 372-380.
19. Dethlefsen, L., Huse, S., Sogin, M. L., and Relman, D. A. (2008). The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 6:e280. doi: 10.1371/journal.pbio.0060280
20. Dethlefsen, L., and Relman, D. A. (2011). Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1), 4554-4561.
21. Dominguez-Bello, M. G., Costello, E. K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., et al. (2010). Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. U.S.A. 107, 11971-11975.
22. Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J. A., Hujer, A. M., et al. (2000). Effect of antibiotic therapy on the density of vancomycinresistant enterococci in the stool of colonized patients. N. Engl. J. Med. 343, 1925-1932.
23. Ducluzeau, R., Ladire, M., Callut, C., Raibaud, P., and Abrams, G. D. (1977). Antagonistic effect of extremely oxygen-sensitive clostridia from the microflora of conventional mice and of Escherichia coli against Shigella flexneri in the digestive tract of gnotobiotic mice. Infect. Immun. 17, 415-424.
24. Durban, A., Abellan, J. J., Jimenez-Hernandez, N., Ponce, M., Ponce, J., Sala, T., et al. (2011). Assessing gut microbial diversity from feces and rectal mucosa. Microb. Ecol. 61, 123-133.
25. Duval-Iflah, Y., Raibaud, P., Tancrede, C., and Rousseau, M. (1980). R-plasmic transfer from Serratia liquefaciens to Escherichia coli in vitro and in vivo in the digestive tract of gnotobiotic mice associated with human fecal flora. Infect. Immun. 28, 981-990.
26. Fantin, B., Duval, X., Massias, L., Alavoine, L., Chau, F., Retout, S., et al. (2009). Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. J. Infect. Dis. 200, 390-398.
27. Fouhy, F., Guinane, C. M., Hussey, S., Wall, R., Ryan, C. A., Dempsey, E. M., et al. (2012). High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob. Agents Chemother. 56, 5811-5820.
28. Gough, E., Shaikh, H., and Manges, A. R. (2011). Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin. Infect. Dis. 53, 994-1002.
29. Hamilton, M. J., Weingarden, A. R., Sadowsky, M. J., and Khoruts, A. (2012). Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am. J. Gastroenterol. 107, 761-767.
30. Hooton, T. (2012). Uncomplicated urinary tract infection. N. Engl. J. Med. 366, 1028-1037.
31. Khoder, M., Tsapis, N., Domergue-Dupont, V., Gueutin, C., and Fattal, E. (2010). Removal of residual colonic ciprofloxacin in the rat by activated charcoal entrapped within zinc-pectinate beads. Eur. J. Pharm. Sci. 41, 281-288.
32. Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., et al. (2010). Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10, 597-602.
33. Lagier, J. C., Armougom, F., Million, M., Hugon, P., Pagnier, I., Robert, C., et al. (2012a). Microbial culturomics: paradigm shift in the human gut microbiome study. Clin. Microbiol. Infect. 18, 1185-1193.
34. Lagier, J. C., Million, M., Hugon, P., Armougom, F., and Raoult, D. (2012b). Human gut microbiota: repertoire and variations. Front. Cell. Infect. Microbiol. 2:136. doi: 10.3389/fcimb.2012.00136
35. Lerner, A., Romano, J., Chmelnitsky, I., Navon-Venezia, S., Edgar, R., and Carmeli, Y. (2013). Rectal swabs are suitable for quantifying the carriage load of KPCproducing carbapenem-resistant Enterobacteriaceae (CRE). Antimicrob. Agents Chemother. 57, 1474-1479.
36. Lesprit, P., and Brun-Buisson, C. (2008). Hospital antibiotic stewardship. Curr. Opin. Infect. Dis. 21, 344-349.
37. Ley, R. E., Backhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., and Gordon, J. I. (2005). Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U.S.A. 102, 11070-11075.
38. Ley, R. E., Peterson, D. A., and Gordon, J. I. (2006). Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124, 837-848.
39. Lidin-Janson, G., Kaijser, B., Lincoln, K., Olling, S., and Wedel, H. (1978). The homogeneity of the faecal coliform flora of normal school-girls, characterized by serological and biochemical properties. Med. Microbiol. Immunol. 164, 247-253.
40. Lucet, J. C., Decre, D., Fichelle, A., Joly-Guillou, M. L., Pernet, M., Deblangy, C., et al. (1999). Control of a prolonged outbreak of extended-spectrum beta-lactamaseproducing Enterobacteriaceae in a university hospital. Clin. Infect. Dis. 29, 1411-1418.
41. MacDougall, C., and Polk, R. E. (2005). Antimicrobial stewardship programs in health care systems. Clin. Microbiol. Rev. 18, 638-656.
42. MacPherson, D. W., Gushulak, B. D., Baine, W. B., Bala, S., Gubbins, P. O., Holtom, P., et al. (2009). Population mobility, globalization, and antimicrobial drug resistance. Emerg. Infect. Dis. 15, 1727-1732.
43. Michea-Hamzehpour, M., Auckenthaler, R., Kunz, J., and Pechere, J. C. (1988). Effect of a single dose of cefotaxime or ceftriaxone on human faecal flora. A doubleblind study. Drugs 35(Suppl. 2), 6-11.
44. Moreno, E., Andreu, A., Pigrau, C., Kuskowski, M., Johnson, J., and Prats, G. (2008). Relationships between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. J. Clin. Microbiol. 46, 2529-2534.
45. Nord, C. E., and Edlund, C. (1989). Clinical impact of newer quinolones: influence on normal microflora. J. Chemother. 1, 18-23.
46. Nord, C. E., Kager, L., and Heimdahl, A. (1984). Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am. J. Med. 76, 99-106.
47. Nordmann, P., Cuzon, G., and Naas, T. (2009). The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 9, 228-236.
48. Nuotio, L., Schneitz, C., and Nilsson, O. (2013). Effect of competitive exclusion in reducing the occurrence of Escherichia coli producing extended-spectrum β- lactamases in the ceca of broiler chicks. Poult. Sci. 92, 250-254.
49. Oostdijk, E. A., De Smet, A. M., Kesecioglu, J., and Bonten, M. (2012). Decontamination of cephalosporin-resistant Enterobacteriaceae during selective digestive tract decontamination in intensive care units. J. Antimicrob. Chemother. 67, 2250-2253.
50. Oostdijk, E. A., De Smet, A. M., Kesecioglu, J., Bonten, M. J., and Dutch SOD-SDD Trialists Group. (2011). The role of intestinal colonization with gram-negative bacteria as a source for intensive care unit-acquired bacteremia. Crit. Care Med. 39, 961-966.
51. Overdevest, I., Willemsen, I., Rijnsburger, M., Eustace, A., Xu, L., Hawkey, P., et al. (2011). Extended-spectrum beta-lactamase genes of Escherichia coli in chicken meat and humans, The Netherlands. Emerg. Infect. Dis. 17, 1216-1222.
52. Peterson, L. R. (2009). Bad bugs, no drugs: no ESCAPE revisited. Clin. Infect. Dis. 49, 992-993.
53. Pitout, J. D. (2009). IPSAT P1A, a class A beta-lactamase therapy for the prevention of penicillin-induced disruption to the intestinal microflora. Curr. Opin. Investig. Drugs 10, 838-844.
54. Pitout, J. D., and Laupland, K. B. (2008). Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8, 159-166.
55. Plos, K., Connell, H., Jodal, U., Marklund, B. I., Marild, S., Wettergren, B., et al. (1995). Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children. J. Infect. Dis. 171, 625-631.
56. Poirel, L., Potron, A., and Nordmann, P. (2012). OXA-48-like carbapenemases: the phantom menace. J. Antimicrob. Chemother. 67, 1597-1606.
57. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., et al. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65.
58. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., et al. (2012). A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60.
59. Queenan, A. M., and Bush, K. (2007). Carbapenemases: the versatile beta-lactamases. Clin. Microbiol. Rev. 20, 440-458.
60. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., and Medzhitov, R. (2004). Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241.
61. Round, J. L., and Mazmanian, S. K. (2009). The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9, 313-323.
62. Ruimy, R., Brisabois, A., Bernede, C., Skurnik, D., Barnat, S., Arlet, G., et al. (2010). Organic and conventional fruits and vegetables contain equivalent counts of Gram-negative bacteria expressing resistance to antibacterial agents. Environ. Microbiol. 12, 608-615.
63. Ruppe, E., Hem, S., Lath, S., Gautier, V., Ariey, F., Sarthou, J. L., et al. (2009). CTX-M beta-lactamases in Escherichia coli from community-acquired urinary tract infections, Cambodia. Emerg. Infect. Dis. 15, 741-748.
64. Saidel-Odes, L., Polachek, H., Peled, N., Riesenberg, K., Schlaeffer, F., Trabelsi, Y., et al. (2012). A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage. Infect. Control Hosp. Epidemiol. 33, 14-19.
65. Skurnik, D., Nucci, A., Ruimy, R., Lasocki, S., Muller-Serieys, C., Montravers, P., et al. (2010). Emergence of carbapenem-resistant Hafnia: the fall of the last soldier. Clin. Infect. Dis. 50, 1429-1431.
66. Sommer, M. O., Dantas, G., and Church, G. M. (2009). Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 325, 1128- 1131.
67. Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G., and Edwards, J. E. Jr. (2004). Trends in antimicrobial drug development: implications for the future. Clin. Infect. Dis. 38, 1279-1286.
68. Stappenbeck, T. S., Hooper, L. V., and Gordon, J. I. (2002). Developmental regulation of intestinal angiogenesis by indigenous microbes via paneth cells. Proc. Natl. Acad. Sci. U.S.A. 99, 15451-15455.
69. Stearns, J. C., Lynch, M. D., Senadheera, D. B., Tenenbaum, H. C., Goldberg, M. B., Cvitkovitch, D. G., et al. (2011). Bacterial biogeography of the human digestive tract. Sci. Rep. 1, 170.
70. Tancrede, C. H., and Andremont, A. O. (1985). Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies. J. Infect. Dis. 152, 99-103.
71. Tangden, T., Cars, O., Melhus, A., and Lowdin, E. (2010). Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended -spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob. Agents Chemother. 54, 3564-3568.
72. Tannock, G. W., Tiong, I. S., Priest, P., Munro, K., Taylor, C., Richardson, A., et al. (2011). Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrug-resistant E. coli by elderly residents in long-term care facilities. J. Med. Microbiol. 60, 366-370.
73. Tarkkanen, A. M., Heinonen, T., Jogi, R., Mentula, S., Van Der Rest, M. E., Donskey, C. J., et al. (2009). P1A recombinant beta-lactamase prevents emergence of antimicrobial resistance in gut microflora of healthy subjects during intravenous administration of ampicillin. Antimicrob. Agents Chemother. 53, 2455-2462.
74. Taur, Y., Xavier, J. B., Lipuma, L., Ubeda, C., Goldberg, J., Gobourne, A., et al. (2012). Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin. Infect. Dis. 55, 905-914.
75. Tosh, P. K., and McDonald, L. C. (2012). Infection control in the multidrug-resistant era: tending the human microbiome. Clin. Infect. Dis. 54, 707-713.
76. Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., and Gordon, J. I. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031.
77. Turnbaugh, P. J., Quince, C., Faith, J. J., Mchardy, A. C., Yatsunenko, T., Niazi, F., et al. (2010). Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc. Natl. Acad. Sci. U.S.A. 107, 7503-7508.
78. Ubeda, C., Bucci, V., Caballero, S., Djukovic, A., Toussaint, N. C., Equinda, M., et al. (2013). Intestinal microbiota containing Barnesiella cures vancomycin-resistant Enterococcus faecium colonization. Infect. Immun. 81, 965-973.
79. van der Waaij, D., Berghuis-De Vries, J. M., and Lekkerkerk, L.-V. (1971). Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J. Hyg. (Lond.) 69, 405-411.
80. van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., De Vos, W. M., et al. (2013). Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368, 407-415.
81. Vaux, S., Carbonne, A., Thiolet, J. M., Jarlier, V., and Coignard, B. (2011). Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011. Euro Surveill. 16, pii: 19880.
82. Vollaard, E. J., and Clasener, H. A. (1994). Colonization resistance. Antimicrob. Agents Chemother. 38, 409-414.
83. Walsh, T. R., Weeks, J., Livermore, D. M., and Toleman, M. A. (2011). Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. 11, 355-362.
84. Wellington, E., Boxall, A., Cross, P., Feil, E., Gaze, W., Hawkey, P., et al. (2013). The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria. Lancet Infect. Dis. 13, 155-165.
85. Whitman, W. B., Coleman, D. C., and Wiebe, W. J. (1998). Prokaryotes: the unseen majority. Proc. Natl. Acad. Sci. U.S.A. 95, 6578-6583.
86. Willemsen, I., Van Der Kooij, T., Van Benthem, B., Wille, J., and Kluytmans, J. (2010). Appropriateness of antimicrobial therapy: a multicentre prevalence survey in the Netherlands, 2008-2009. Euro Surveill. 15, pii: 19715.
87. Woerther, P. L., Angebault, C., Jacquier, H., Hugede, H. C., Janssens, A. C., Sayadi, S., et al. (2011). Massive increase, spread, and exchange of extended spectrum beta-lactamase-encoding genes among intestinal Enterobacteriaceae in hospitalized children with severe acute malnutrition in Niger. Clin. Infect. Dis. 53, 677-685.
88. Yamamoto, S., Tsukamoto, T., Terai, A., Kurazono, H., Takeda, Y., and Yoshida, O. (1997). Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. J. Urol. 157, 1127-1129.
89. Youssef, M., Al Shurman, A., Chachaty, E., Bsoul, A. R., and Andremont, A. (1998). Use of molecular typing to investigate bacterial translocation from the intestinal tract in malnourished children with Gram-negative bacteremia. Clin. Microbiol. Infect. 4, 70-74.